Drug concentration measurement for HIV prevention targets: toward a population-based HIV impact assessment (phia) for prep - sub-saharan africa (SSA) is home to two-thirds of all people living with…

Active Project Grant Awarded Last action

Award ID
R01AI179417
Recipient
Awarding agency
Obligated
$4,746,709

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 55% complete
Place of performance
New York, NY 10016, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Drug concentration measurement for HIV prevention targets: toward a population-based HIV impact assessment (phia) for prep - sub-saharan africa (SSA) is home to two-thirds of all people living with HIV (plhiv). Widely-adopted targets such as "95-95-95" (diagnosing =95% of plhiv, treating =95% of those diagnosed, and achieving viral load suppression in =95% of those on treatment) have fueled tremendous progress in access and effective use of HIV treatment, with surveillance from population HIV impact assessments (phias) used to monitor progress. Although these efforts have reduced HIV incidence and mortality, HIV/aids remains the leading cause of death among SSA adults, and HIV incidence remains high, with many regions not on track to achieve the sustainable development goal (SDG) of HIV incidence

Transactions

Action Obligated Date
Amendment $791,774
Amendment $821,361
Amendment $821,361
Amendment $85,637
Amendment $189,885
Amendment $189,885
Amendment $615,602
Amendment $615,602
Original award $615,602

Subawards

Subrecipient Amount Awarded
The Massachusetts General Hospital This study will estimate the relationship between plasma concentrations of PrEP drugs and their effects on reducing HIV acquisition risk, the relationship… $132,911
Fred Hutchinson Cancer Research Center $553,770
The Massachusetts General Hospital $136,798
Fred Hutchinson Cancer Research Center $539,876
The Massachusetts General Hospital Drug concentration measurement for HIV prevention targets: toward a population-based HIV impact assessment (PHIA) for PrEP - Resubmission - 1 $106,890
Fred Hutchinson Cancer Research Center $285,696

Quick answers

Who received award R01AI179417?

R01AI179417 was awarded to New York University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 15, 2024.

How much is award R01AI179417 worth?

$4,746,709 has been obligated on R01AI179417.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login